c-Met expression in gastric cancer with liver metastasis

Oncology

Volumn 63, Issue 3, 2002, Pages 286-296

  Amemiya, Hideki ^a   Kono, Koji ^a   Itakura, Jun ^a   Tang, Rui Feng ^a   Takahashi, Akihiro ^a   An, Feng Qi ^a   Kamei, Shigeo ^a   Iizuka, Hidehiko ^a   Fujii, Hideki ^a   Matsumoto, Yoshiro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

c Met; Gastric cancer, stage IV; Hepatocyte growth factor; Immunohistochemistry; Liver metastasis; Prognosis; Proliferating cell nuclear antigen; Semiquantitative reverse transcriptase polymerase chain reaction

Indexed keywords

CYCLINE; MESSENGER RNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ARTICLE; CANCER SURVIVAL; CARCINOMA CELL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; STROMA CELL; SURVIVAL RATE;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SIGNET RING CELL; DNA PRIMERS; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-MET; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0036966942     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065477     Document Type: Article

References (37)

1. Tas F, Aykan NF, Aydiner A, Uygun K, Basaran M, Camlica H, Topuz E: The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival. Am J Clin Oncol 2000;23:53-57.
2. Sobin LH, Wittekind Ch (eds): International Union against Cancer (UICC). TNM Classification of Malignant Tumors, ed 5. New York, Wiley, 1997, pp 59-65.
3. Hundahl SA, Phillips JL, Menck HR: The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth edition American Joint Committee on Cancer Staging, proximal disease, and the 'different disease' hypothesis. Cancer 2000;88:921-932.
4. Ochiai T, Sasako M, Mizuno S, Kinoshita T, Takayama T, Kosuge T, Yamazaki S, Maruyama K: Hepatic resection for metastatic tumours from gastric cancer: Analysis of prognostic factors. Br J Surg 1994;81:1175-1178.
5. Bedikian AY, Chen TT, Khankhanian N, Heilbrun LK, McBride CM, McMurtrey MJ, Bodey GP: The natural history of gastric cancer and prognostic factors influencing survival. J Clin Oncol 1984;2:305-310.
6. Saito A, Korenaga D, Sakaguchi Y, Ohno S, Ichiyoshi Y, Sugimachi K: Surgical treatment for gastric carcinomas with concomitant hepatic metastasis. Hepatogastroenterology 1996;43:560-564.
7. Nakamura T, Nawa K, Ichihara A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984;122:1450-1459.
8. Montesano R, Matsumoto K, Nakamura T, Orci L: Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991;67:901-908.
9. Stoker M, Gherardi E, Perryman M, Gray J: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987;327:239-242.
10. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coofer A, Comoglio PM: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992;119:629-641.
11. Michieli P, Basilico C, Pennacchietti S, Maffe A, Tamagnone L, Giordano S, Bardelli A, Comoglio PM: Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists. Oncogene 1999;18:5221-5231.
12. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude GF: Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci USA 1987;84:6379-6383.
13. Prat M, Narsimhan RP, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM: The receptor encoded by the human c-Met oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 1991;49:323-328.
14. Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S, Giordano S, Plebani M, Gespach C, Comoglio PM: Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1995;1:147-154.
15. Di Renzo MF, Olivero M, Ferro S, Pratt M, Bongarzone I, Pilotti S, Belfiore A, Costantino A, Vigneri R, Pierotti MA, Comoglio PM: Overexpression of c-Met/HGF receptor gene in human thyroid carcinomas. Oncogene 1992;7:2549-2553.
16. Di Renzo MF, Olivero M, Katsaros D, Crepaldi T, Gaglia P, Zola P, Sismondi P, Comoglio PM: Overexpression of the Met/HGF receptor in ovarian cancer. Int J Cancer 1994;58:658-662.
17. Natali PG, Prat M, Nicotra MR, Bigotti A, Olivero M, Comoglio PM, Di Renzo MF: Overexpression of the met/HGF receptor in renal cell carcinomas. Int J Cancer 1996;69:212-217.
18. Harvey P, Warn A, Newman P, Perry LJ, Ball RY, Warn RM: Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas. J Pathol 1996;180:389-394.
19. Jin L, Fuchs A, Schmitt SJ, Yao Y, Joseph A, Lamszus K, Park M, Goldberg ID, Rosen EM: Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer 1997;79:749-760.
20. Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H, Tahara E: Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 1992;189:227-232.
21. Kaji M, Yonemura Y, Harada S, Liu X, Terada I, Yamamoto H: Participation of c-met in the progression of human gastric cancers: Anti c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells. Cancer Gene Ther 1996:3:393-404.
22. Amemiya H, Kono K, Mori Y, Takahashi A, Ichihara F, Iizuka H, Sekikawa T, Matsumoto Y: High frequency of c-Met expression in gastric cancers producing alpha-fetoprotein. Oncology 2000;59:145-151.
23. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
24. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, Comoglio PM: Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 1989;339:155-156.
25. Giordano S, Di Renzo MF, Narsimhan RP, Cooper CS, Rosa C, Comoglio PM: Biosynthesis of the protein encoded by the c-met protooncogene. Oncogene 1989;4:1383-1388.
26. Wu CW, Li AFY, Chi CW, Chung WW, Liu TY, Liu WY, P'eng FK: Hepatocyte growth factor and Met/HGF receptors in patients with gastric adenocarcinoma. Oncol Rep 1998;5:817-822.
27. Fujita S, Sugano K: Expression of c-met protooncogene in primary colorectal cancer and liver metastases. Jpn J Clin Oncol 1997;27:378-383.
28. Nakamura T, Nawa K, Ichihara A, Kaise A, Nishino T: Subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 1987;224:311-318.
29. Rosen E, Goldberg ID, Karinski BM, Buckholz T, Vinter DW: Smooth muscle releases an epithelial scatter factor which binds to heparin. In Vitro Cell Dev Biol 1989;25:163-173.
30. Tajima H, Matsumoto K, Nakamura T: Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Exp Cell Res 1992;202:423-431.
31. Zarnegar R, Michalopoulos GK: The many faces of hepatocyte growth factor: From hepatopoiesis to hematopoiesis. J Cell Biol 1995;129:1177-1180.
32. Matsumoto K, Nakamura T: Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 1997;239:639-644.
33. Rong S, Bodescot M, Blair D, Dunn J, Nakamura T, Mizuno K, Park M, Chan A, Aaronson S, Vande Woude GF: Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol 1992;12:5152-5158.
34. Jeffers M, Rong S, Anver M, Vande Woude GF: Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastatic phenotype in C127 cells. Oncogene 1996;13:853-856.
35. Hammond DE, Urbe S, Vande Woude GF, Clague MJ: Down-regulation of MET, the receptor for hepatocyte growth factor. Oncogene 2001;20:2761-2770.
36. Ponzetto C, Giordano S, Peverali F, Della Valle G, Abate ML, Vaula G, Comoglio PM: c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. Oncogene 1991;6:553-559.
37. Mori M, Kakeji Y, Adachi Y, Moriguchi S, Maehara Y, Sugimachi K, Jessup JM, Chen LB, Steele GD Jr: The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer. Surgery 1993;113:683-690.